{
    "id": "0565",
    "question": "A 63-year-old man comes to the physician for the evaluation of an unintentional 10-kg (22-lb) weight loss over the past 6 months. During this period, the patient has had recurrent episodes of high-grade fever, night sweats, and feelings of fatigue. Two months ago, he had herpes zoster that was treated with acyclovir. He appears pale. Temperature is 38.5\u00b0C (101.3\u00b0F), pulse is 90/min, and blood pressure 130/80 mm Hg. Physical examination shows generalized painless lymphadenopathy. The liver and the spleen are palpated 2\u20133 cm below the right and the left costal margin, respectively. Laboratory studies show:\nHematocrit 42%\nLeukocyte count 15,000/mm3\nSegmented neutrophils 46%\nEosinophils 1%\nLymphocytes 50%\nMonocytes 3%\nPlatelet count 120,000/mm3\nBlood smear shows mature lymphocytes that rupture easily and appear as artifacts on a blood smear. Flow cytometry shows lymphocytes expressing CD5, CD19, CD20, and CD23. Which of the following is the most appropriate treatment?\"",
    "options": {
        "A": "All-trans retinoic acid",
        "B": "Fludarabine, cyclophosphamide, rituximab",
        "C": "Observation and disease progression monitoring",
        "D": "Imatinib only\n\""
    },
    "answer": "B",
    "predict": "{\"step_by_step_thinking\": \"To approach this question, let's break down the key findings from the patient's presentation and laboratory results: 1. Unintentional weight loss, high-grade fever, night sweats, and fatigue are classic symptoms of a hematological malignancy. 2. The patient's physical examination reveals generalized painless lymphadenopathy, which is a common finding in lymphoproliferative disorders. 3. The palpable liver and spleen (hepatosplenomegaly) further supports the suspicion of a hematological malignancy. 4. The laboratory results show a low hematocrit (42%) and thrombocytopenia (platelet count 120,000/mm^3), which indicate bone marrow involvement. 5. The blood smear shows mature lymphocytes that rupture easily and appear as artifacts, which is consistent with a lymphoproliferative disorder. 6. Flow cytometry results showing lymphocytes expressing CD5, CD19, CD20, and CD23 are highly suggestive of Chronic Lymphocytic Leukemia (CLL), a type of B-cell lymphoma. Given these findings, the most appropriate treatment would be a regimen that targets B-cell malignancies. Fludarabine, cyclophosphamide, and rituximab are a common treatment combination for CLL, making option B the most appropriate choice. Option A, All-trans retinoic acid, is used in the treatment of acute promyelocytic leukemia (APL), which is not suggested by the patient's presentation. Option C, observation and disease progression monitoring, is not appropriate given the patient's significant symptoms and laboratory findings. Option D, Imatinib, is used in the treatment of chronic myeloid leukemia (CML) and not CLL.\", \"answer_choice\": \"B\"}",
    "snippets": [],
    "scores": [],
    "execution_time": 10.424317836761475
}